# An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM

> **NCT07867886** · NA · NOT_YET_RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 30 (estimated)

## Conditions studied

- Recurrent Glioblastoma

## Interventions

- **DEVICE:** Device: TheraSphere GBM treatment of TheraSphere GBM device

## Key facts

- **NCT ID:** NCT07867886
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2028-10-28
- **Final completion:** 2029-09-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07867886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07867886, "An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07867886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
